Barely Significant
← all excerpts

CB<sub>1</sub> Receptor Antagonist Selonabant (ANEB-001) Blocks Acute THC Effects in Healthy Volunteers: A Phase II Randomized Controlled Trial.

Clin Pharmacol Ther · 2025 · PMC11993283 · PMID 39898464

Europe PMCDOI
1
hedged sentence
—
closest p
—
boldest claim

The sentences

highly significantno p-value reported
Although selonabant had highly significant treatment effects on VAS “Feeling High” and “Alertness,” this was not consistently observed for body sway and heart rate.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.